1,942
Views
38
CrossRef citations to date
0
Altmetric
Research Paper

Crohn disease-associated Escherichia coli promote gastrointestinal inflammatory disorders by activation of HIF-dependent responses

, , , , &
Pages 335-346 | Published online: 01 Nov 2011

References

  • Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837 - 48; http://dx.doi.org/10.1016/j.cell.2006.02.017; PMID: 16497592
  • Inagaki H, Suzuki T, Nomoto K, Yoshikai Y. Increased susceptibility to primary infection with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin+ CD44+ T cells in sites of inflammation. Infect Immun 1996; 64:3280 - 7; PMID: 8757865
  • Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427 - 34; http://dx.doi.org/10.1038/nature06005; PMID: 17653185
  • Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417 - 29; http://dx.doi.org/10.1056/NEJMra020831; PMID: 12167685
  • Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007; 42:16 - 25; http://dx.doi.org/10.1007/s00535-006-1995-7; PMID: 17322989
  • Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009; 206:2179 - 89; http://dx.doi.org/10.1084/jem.20090741; PMID: 19737864
  • Carvalho FA, Barnich N, Sauvanet P, Darcha C, Gelot A, Darfeuille-Michaud A. Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin. Inflamm Bowel Dis 2008; 14:1051 - 60; http://dx.doi.org/10.1002/ibd.20423; PMID: 18338780
  • Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007; 117:1566 - 74; http://dx.doi.org/10.1172/JCI30504; PMID: 17525800
  • Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006; 441:437 - 43; http://dx.doi.org/10.1038/nature04871; PMID: 16724055
  • Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16:4604 - 13; PMID: 8756616
  • Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671 - 4; http://dx.doi.org/10.1038/386671a0; PMID: 9109485
  • Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008; 14:6735 - 41; http://dx.doi.org/10.1158/1078-0432.CCR-07-4843; PMID: 18980965
  • Danese S, Sans M, Spencer DM, Beck I, Donate F, Plunkett ML, et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 2007; 56:855 - 62; http://dx.doi.org/10.1136/gut.2006.114314; PMID: 17170016
  • Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 2009; 136:585 95; http://dx.doi.org/10.1053/j.gastro.2008.09.064; PMID: 19013462
  • Mariani F, Sena P, Marzona L, Riccio M, Fano R, Manni P, et al. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 2009; 279:221 - 9; http://dx.doi.org/10.1016/j.canlet.2009.02.001; PMID: 19268443
  • Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter KC, et al. Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol 2003; 56:209 - 13; http://dx.doi.org/10.1136/jcp.56.3.209; PMID: 12610101
  • Vannay A, Sziksz E, Prokai A, Veres G, Molnar K, Nagy Szakal D, et al. Increased expression of hypoxia inducible factor 1alpha in coeliac disease. Pediatr Res 2010; 68:118 22; http://dx.doi.org/10.1203/PDR.0b013e3181e5bc96; PMID: 20453713
  • Rolhion N, Barnich N, Bringer MA, Glasser AL, Ranc J, Hebuterne X, et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut 2010; 59:1355 - 62; http://dx.doi.org/10.1136/gut.2010.207456; PMID: 20587550
  • Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 2008; 134:156 - 65; http://dx.doi.org/10.1053/j.gastro.2007.10.012; PMID: 18166353
  • Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 2008; 586:4055 - 9; http://dx.doi.org/10.1113/jphysiol.2008.157669; PMID: 18599532
  • Krogfelt KA, Bergmans H, Klemm P. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae. Infect Immun 1990; 58:1995 - 8; PMID: 1971261
  • Barnich N, Boudeau J, Claret L, Darfeuille-Michaud A. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol 2003; 48:781 - 94; http://dx.doi.org/10.1046/j.1365-2958.2003.03468.x; PMID: 12694621
  • Smith KD, Ozinsky A. Toll-like receptor-5 and the innate immune response to bacterial flagellin. Curr Top Microbiol Immunol 2002; 270:93 - 108; http://dx.doi.org/10.1007/978-3-642-59430-4_6; PMID: 12467246
  • O'Neill LA, Bryant CE, Doyle SL. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 2009; 61:177 - 97; http://dx.doi.org/10.1124/pr.109.001073; PMID: 19474110
  • Pages G, Pouyssegur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene–a concert of activating factors. Cardiovasc Res 2005; 65:564 - 73; http://dx.doi.org/10.1016/j.cardiores.2004.09.032; PMID: 15664382
  • Eaves-Pyles T, Allen CA, Taormina J, Swidsinski A, Tutt CB, Jezek GE, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol 2008; 298:397 - 409; http://dx.doi.org/10.1016/j.ijmm.2007.05.011; PMID: 17900983
  • Semiramoth N, Gleizes A, Turbica I, Sandre C, Gorges R, Kansau I, et al. Escherichia coli type 1 pili trigger late IL-8 production by neutrophil-like differentiated PLB-985 cells through a Src family kinase- and MAPK-dependent mechanism. J Leukoc Biol 2009; 85:310 - 21; http://dx.doi.org/10.1189/jlb.0608350; PMID: 19015376
  • Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882 - 5; PMID: 11489966
  • Frede S, Stockmann C, Freitag P, Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. Biochem J 2006; 396:517 - 27; http://dx.doi.org/10.1042/BJ20051839; PMID: 16533170
  • Jung Y, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem J 2003; 370:1011 - 7; http://dx.doi.org/10.1042/BJ20021279; PMID: 12479793
  • Kim KS, Rajagopal V, Gonsalves C, Johnson C, Kalra VK. A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 2006; 177:7211 - 24; PMID: 17082639
  • Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 2008; 134:2036 48; http://dx.doi.org/10.1053/j.gastro.2008.03.009; PMID: 18439915
  • Imtiyaz HZ, Williams EP, Hickey MM, Patel SA, Durham AC, Yuan LJ, et al. Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 2010; 120:2699 - 714; http://dx.doi.org/10.1172/JCI39506; PMID: 20644254
  • Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127:80 - 93; http://dx.doi.org/10.1053/j.gastro.2004.03.054; PMID: 15236175
  • Bronowski C, Smith SL, Yokota K, Corkill JE, Martin HM, Campbell BJ, et al. A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli. Microbiology 2008; 154:571 - 83; http://dx.doi.org/10.1099/mic.0.2007/013086-0; PMID: 18227261
  • Boudeau J, Barnich N, Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 2001; 39:1272 - 84; http://dx.doi.org/10.1111/j.1365-2958.2001.02315.x; PMID: 11251843
  • Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998; 115:1405 - 13; http://dx.doi.org/10.1016/S0016-5085(98)70019-8; PMID: 9834268
  • Chan CH, Stanners CP. Novel mouse model for carcinoembryonic antigen-based therapy. Mol Ther 2004; 9:775 - 85; http://dx.doi.org/10.1016/j.ymthe.2004.03.009; PMID: 15194045
  • Cane G, Ginouves A, Marchetti S, Busca R, Pouyssegur J, Berra E, et al. HIF-1alpha mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell Microbiol 2010; 12:640 - 53; http://dx.doi.org/10.1111/j.1462-5822.2009.01422.x; PMID: 20039880
  • Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 2010; 102:1627 - 35; http://dx.doi.org/10.1038/sj.bjc.6605690; PMID: 20461082

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.